Investor

GE HealthCare began trading on Nasdaq as an independent company on Wednesday.

The Oregon Health Authority said the deal is not likely to greatly reduce access to affordable care in the state, but it placed some conditions on its approval.

PharmStars founder and CEO Naomi Fried talks about the company's call for applications to digital health companies that aim to improve women's health and health equity for underserved populations.

Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.

The consortium's collaboration and partnership opportunities may be the most beneficial to the HIMSS audience, according to James Hury, the Translational Research Institute for Space Health's chief innovation officer.

Although investment slowed for startups, leaders noted several big deals in digital health, particularly among retail players.

James Hury, the Translational Research Institute for Space Health's deputy director and chief innovation officer explains the ways space exploration companies work with healthcare innovators to examine astronaut health and advance healthcare on the ground.

Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.

Execs said investors will focus on companies with evidence of market fit, established business models and those achieving measurable health outcomes.   

The year was plagued by layoffs, slowing investments and an increased need for companies to prove their market value.